2003
DOI: 10.1023/a:1021128017974
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: To test the hypothesis that mutated beta2-subunits of the L-type calcium channel could serve as a decoy and interdict calcium channel trafficking and function, we engineered a beta2 subunit that contained the beta interaction domain for alpha1c subunit interaction, but lacked N- and C-terminal domains that might be essential for sarcolemmal localization. An adenoviral vector was constructed containing the gene for the beta-interaction domain (BID) fused to green fluorescence protein (GFP), using a vector conta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…21,22 The Ca v β subunits co-assemble with pore-forming α-subunits during channel biogenesis to promote the trafficking of the Ca 2+ channel complex from the ER to the PM. 14,19 Although Ca v β are postulated to mask an ER retention signal in α-subunits as a mechanism to target Ca 2+ channels to the cell surface, no specific motif has been identified.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…21,22 The Ca v β subunits co-assemble with pore-forming α-subunits during channel biogenesis to promote the trafficking of the Ca 2+ channel complex from the ER to the PM. 14,19 Although Ca v β are postulated to mask an ER retention signal in α-subunits as a mechanism to target Ca 2+ channels to the cell surface, no specific motif has been identified.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, Fan et al 22 designed mutant Ca v β subunits that interact with α 1C intracellularly, but lack the motifs required to target the Ca v 1.2 channel complex to the PM. These β subunit “decoys” represent potential therapeutics to reduce Ca v 1.2 surface expression in cardiovascular pathologies characterized by an overabundance of Ca v 1.2 channels.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation